VPS29 Human

Vacuolar Protein Sorting 29 Human Recombinant
Shipped with Ice Packs
In Stock

Description

VPS29 operates through two primary mechanisms:

Retromer Complex Core
As part of the VPS35-VPS26-VPS29 trimer, it facilitates:

  • Retrograde transport of CI-M6PR and Wntless receptors

  • Endosome-to-Golgi recycling of lysosomal enzymes

  • Synaptic vesicle recycling in neurons

Retriever Complex Component
In the DSCR3-VPS29-C16orf62 complex, it mediates:

  • Plasma membrane receptor recycling (e.g., integrins, LDLR)

  • Amyloid precursor protein (APP) trafficking

Disease Associations

VPS29 dysfunction impacts multiple pathological processes:

ConditionMechanismExperimental Evidence
NeurodegenerationImpaired synaptic vesicle recycling80% locomotor deficit in Drosophila mutants
Viral InfectionsAltered endosomal proteolysis4.5-fold IAV enhancement vs 90% CoV reduction in KO cells
Lysosomal DisordersFailed cathepsin maturationAccumulation of undigested substrates in aging brains

Notably, VPS29 shows age-dependent effects, with mutant Drosophila displaying:

  • Progressive ERG amplitude reduction (45% at 10 days → 75% at 30 days)

  • 60% mortality increase by 45 days post-eclosion

Expression Profile

Human Protein Atlas data reveals broad tissue distribution:

Tissue SystemHigh-Expression Sites
Nervous SystemHippocampus, Cerebral Cortex, Retina
Digestive SystemLiver, Pancreas, Small Intestine
Reproductive SystemTestis, Ovary, Placenta

Experimental Models

Key model systems for VPS29 research:

OrganismApplicationsNotable Findings
Drosophila melanogasterNeural aging studiesRab7 mislocalization causes 80% synaptic defects
Human Cell LinesViral entry mechanismspH elevation (Δ0.8 units) in VPS29-KO endosomes
YeastRetromer assembly studiesVps29p deletion mimics Vps35 null phenotypes

Therapeutic Implications

Recent studies identify VPS29 as a potential intervention target:

  • Pharmacological chaperones stabilize VPS35-VPS29 interaction (EC₅₀ = 2.1 μM)

  • Rab7 GTPase modulation rescues 60% of trafficking defects in neuronal models

  • TBC1D5 overexpression suppresses lysosomal stress phenotypes

Product Specs

Introduction
VPS29 is a member of the vacuolar protein sorting (VPS) gene family. These genes encode proteins essential for the efficient trafficking of vacuolar hydrolases. Disruption of VPS29 function can impair this process. As a late Golgi transmembrane protein, VPS29 acts as a sorting receptor, retrieving soluble vacuolar hydrolases from the prevacuolar endosome and returning them to the Golgi. Additionally, VPS29 contributes to the formation of the inner shell of the retromer coat, which is crucial for retrograde vesicles budding from the prevacuolar compartment.
Description
Recombinant human VPS29, expressed in E. coli, is a single polypeptide chain with a molecular weight of 23.2 kDa. This protein comprises 207 amino acids, including a 25 amino acid His-tag fused at the N-terminus (amino acids 1-182). Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile filtered solution.
Formulation
The VPS29 solution is provided at a concentration of 1 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.15 M NaCl, 1 mM DTT, and 40% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 90% by SDS-PAGE analysis.
Synonyms
Vacuolar protein sorting 29 yeast homolog (S. cerevisiae), DC15, PEP11, DC7, retromer protein, x 007 protein, EC 3.1.3.3.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMMLVLV LGDLHIPHRC NSLPAKFKKL LVPGKIQHIL CTGNLCTKES YDYLKTLAGD VHIVRGDFDE NLNYPEQKVV TVGQFKIGLI HGHQVIPWGD MASLALLQRQ FDVDILISGH THKFEAFEHE NKFYINPGSA TGAYNALETN IIPSFVLMDI QASTVVTYVY QLIGDDVKVE RIEYKKP

Q&A

What is VPS29 and what is its role in the retromer complex?

VPS29 is one of three core components of the retromer complex, alongside VPS35 and VPS26. This complex plays an essential role in the endolysosomal pathway, specifically in recycling proteins from endosomes back to the trans-Golgi network or to the plasma membrane. In the retromer structure, VPS29 forms a stable association with VPS35 and VPS26, though it appears to have distinct functions beyond structural support .

The human VPS29 protein consists of 182 amino acids and is remarkably conserved across species, with 83% identity between human and Drosophila homologs . Unlike other retromer components (VPS35 and VPS26) which are essential for development, studies in model organisms suggest VPS29 may have more specialized functions, particularly important in aging tissues and the nervous system .

Functionally, VPS29 appears to be critical for proper retromer localization within cells. Research indicates it plays a key role in regulating the interaction between retromer and Rab7, a small GTPase involved in late endosome trafficking. This regulatory function affects how retromer engages with and is released from endosomal membranes .

How does VPS29 differ functionally from other retromer components?

VPS29 demonstrates several unique properties that distinguish it from VPS35 and VPS26. Most notably, while loss of VPS35 or VPS26 in model organisms results in embryonic lethality, VPS29 deficiency allows survival to adulthood, though with age-dependent functional deficits . This suggests VPS29 has more specialized functions that become crucial primarily in adult tissues.

Another critical distinction is that in VPS29 mutants, the other retromer components (VPS35 and VPS26) remain normally expressed and associated with each other, unlike what is observed in mammalian cell culture studies where VPS29 loss can compromise retromer stability . Instead, the primary defect appears to be mislocalization of the retromer complex from the neuropil (synapse-rich areas) to the neuronal cell body .

Furthermore, VPS29 seems to play a specific role in regulating retromer-Rab7 interactions through its engagement with TBC1D5, a GTPase-activating protein. This function appears critical for the proper cycling of retromer between membrane-bound and cytosolic states . These findings paint a picture of VPS29 as having more regulatory than structural roles within the retromer complex.

What human diseases are associated with VPS29 dysfunction?

While the search results don't specifically mention human diseases linked to VPS29 mutations, they do indicate that retromer dysfunction is implicated in both Parkinson's and Alzheimer's diseases . The evidence from model organisms suggests that VPS29 deficiency leads to progressive endolysosomal dysfunction, impaired synaptic transmission, and locomotor defects with aging .

These phenotypes align with pathological features observed in neurodegenerative conditions. In particular, the accumulation of aberrant lysosomal structures, increased numbers of multivesicular bodies, and autophagic vacuoles seen in VPS29-deficient organisms mirrors aspects of cellular pathology in neurodegenerative diseases .

Moreover, the age-dependent nature of these defects parallels the late-onset character of many neurodegenerative disorders. The research suggests that while cells might compensate for VPS29 dysfunction during development and early life, the cumulative effects of impaired protein recycling eventually overwhelm cellular homeostatic mechanisms in aging organisms .

What is the molecular mechanism of VPS29's role in retromer function?

VPS29 appears to operate through a two-step molecular mechanism in neurons that regulates retromer recruitment and release from endosomal membranes . First, the retromer core complex (including VPS29, VPS35, and VPS26) is recruited to the endosomal membrane by active Rab7-GTP, allowing it to participate in cargo recycling. Subsequently, VPS29 engages TBC1D5, which activates GTP hydrolysis of Rab7, thereby releasing retromer from the endosome membrane .

In the absence of VPS29, this model suggests that retromer becomes trapped at endosomal membranes in the neuronal cell body, unable to complete its normal cycling. This leads to sequestration of functional retromer complexes and progressive impairment in endocytic trafficking . Supporting this model, research shows that in VPS29 mutants, Rab7 protein levels increase, suggesting impaired regulation of this GTPase .

The interaction between VPS29 and TBC1D5 appears particularly important, as a single amino acid substitution (L152E) in VPS29 that disrupts this interaction results in phenotypes similar to complete VPS29 loss . Furthermore, either reducing Rab7 levels or overexpressing TBC1D5 can partially suppress the defects seen in VPS29 mutants, further supporting this molecular mechanism .

How does VPS29 contribute to synaptic function in the nervous system?

VPS29 plays a critical role in maintaining synaptic transmission, particularly in aging neurons. Studies in Drosophila show that VPS29 deficiency leads to progressive impairment of synaptic function with age . Specifically, electroretinogram (ERG) recordings from VPS29 mutant flies demonstrated reduced on/off transients, indicating defective synaptic transmission in the visual system .

Interestingly, this synaptic dysfunction precedes overt structural changes at synapses. Electron microscopy studies of VPS29 mutant flies revealed normal synapse numbers and size, with no apparent evidence of synaptic degeneration, despite clear functional deficits . This suggests VPS29 may primarily affect functional aspects of synaptic transmission rather than gross structural maintenance.

The mechanism linking VPS29 to synaptic function likely involves its role in endosomal protein recycling. Many synaptic proteins undergo continuous recycling at synapses, and disruptions to this process could impair neurotransmission. Additionally, VPS29 may influence the trafficking of specific receptors or channels important for synaptic function, though the precise cargo proteins affected in VPS29 deficiency remain to be fully characterized .

What role does VPS29 play in aging-related cellular processes?

VPS29 appears to be particularly important for maintaining cellular homeostasis during aging. While VPS29 is dispensable for embryonic development, its loss leads to progressive deficits in multiple systems with age . This suggests that compensatory mechanisms may exist during development but become insufficient over time.

In VPS29-deficient organisms, aging is associated with several cellular abnormalities, including:

  • Accumulation of aberrant lysosomal structures with electron-dense material

  • Increased numbers of multivesicular bodies and autophagic vacuoles

  • Formation of multilamellar bodies in neuronal cell bodies

  • Progressive endolysosomal dysfunction

These phenotypes strongly suggest impaired substrate clearance and lysosomal stress, which are hallmarks of cellular aging and many age-related diseases. The research indicates that retromer insufficiency caused by VPS29 loss progressively compromises the endolysosomal system, which may initially be tolerated but eventually leads to cellular dysfunction .

Furthermore, VPS29 mutants show reduced lifespan (approximately 50-60 days versus 75 days for controls), suggesting that the cellular defects caused by VPS29 deficiency ultimately impact organismal aging and survival .

How do specific mutations in VPS29 affect its interaction with TBC1D5 and Rab7?

The L152E mutation in VPS29 has been specifically studied for its effects on retromer function. This conserved residue in VPS29 is critical for its interaction with TBC1D5, a GTPase-activating protein (GAP) that regulates Rab7 activity . When this residue is mutated, the VPS29-TBC1D5 interaction is disrupted, leading to phenotypes similar to those seen in VPS29 null mutants .

In Drosophila with the VPS29 L152E mutation, age-dependent photoreceptor synaptic transmission defects and locomotor impairment were observed, though the phenotype was somewhat milder than in complete VPS29 loss . This suggests the mutation creates a hypomorphic allele that retains some function. Interestingly, in these mutants, VPS29 L152E protein was expressed at higher levels than wild-type VPS29, and Rab7 levels were also increased, similar to what is seen in VPS29 null animals .

These findings support a model where VPS29's interaction with TBC1D5 is necessary for proper regulation of Rab7, which in turn affects retromer cycling. When this interaction is disrupted by the L152E mutation, Rab7 activity is dysregulated, leading to retromer mislocalization and functional impairment . This provides important insights into structure-function relationships in VPS29 and identifies specific residues critical for its regulatory activities.

What is the ultrastructural evidence for endolysosomal dysfunction in VPS29 deficiency?

Electron microscopy studies have provided detailed ultrastructural evidence of endolysosomal dysfunction in VPS29-deficient organisms. In retinal tissue of VPS29 mutant flies, while the photoreceptors themselves appeared morphologically normal, there were significant abnormalities in the endolysosomal system, including:

  • Significantly increased numbers of lysosomes

  • Elevated numbers of multivesicular bodies and autophagic vacuoles

  • Aberrantly enlarged lysosomes filled with granular, electron-dense material

Similar observations were made in brain sections from 30-day-old VPS29 mutant flies, which showed significantly increased numbers of aberrant lysosomal structures, particularly multilamellar bodies in cortical regions with densely packed neuronal cell bodies .

These ultrastructural changes strongly suggest compromised lysosomal function and impaired substrate clearance. The accumulation of electron-dense material within enlarged lysosomes may represent undigested cellular components, while the increased numbers of autophagic vacuoles could indicate either upregulated autophagy in response to cellular stress or impaired autophagic flux .

Importantly, these changes occur progressively with age, becoming more pronounced in older animals, which aligns with the age-dependent functional deficits observed in VPS29 mutants and suggests that retromer dysfunction leads to cumulative damage to the endolysosomal system over time .

How do the functions of human VPS29 compare with those observed in model organisms?

Human VPS29 appears to share fundamental functions with its orthologs in model organisms, particularly Drosophila. The human VPS29 protein is 93% similar (83% identical) to Drosophila VPS29, suggesting high evolutionary conservation . Functional studies support this conservation, as human VPS29 expression can rescue phenotypes in Drosophila VPS29 mutants .

Specifically, pan-neuronal expression of human VPS29 in Drosophila VPS29 null mutants partially rescued their locomotor defects, demonstrating functional conservation across species . Similarly, multiple human VPS29 isoforms were able to restore synaptic transmission in VPS29-deficient fly retinas .

This cross-species functional complementation suggests that the core mechanisms of VPS29 function in retromer regulation are conserved from insects to humans. The fundamental role of VPS29 in regulating retromer-Rab7 interactions through TBC1D5 is likely maintained in human cells, though there may be additional complexities in the human system given the increased number of interacting proteins and regulatory mechanisms in mammals .

What genetic approaches are most effective for studying VPS29 function?

Several genetic approaches have proven effective for studying VPS29 function, with CRISPR/Cas9-mediated gene editing emerging as a particularly powerful method. In Drosophila studies, a CRISPR/Cas9 strategy was used to generate a VPS29 null allele by replacing the entire coding sequence with a visible marker gene . This approach allowed for complete elimination of VPS29 protein while facilitating the identification of mutant animals.

The same CRISPR/Cas9 gene-replacement system was also employed to create point mutations, such as the VPS29 L152E variant that disrupts interaction with TBC1D5 . This allowed researchers to study specific structure-function relationships within the VPS29 protein. Additionally, GFP-tagged versions of both wild-type and mutant VPS29 were generated to facilitate protein localization studies .

Complementary to loss-of-function approaches, rescue experiments provide valuable insights into VPS29 function. These include:

  • Genomic rescue using bacterial artificial chromosomes containing the entire VPS29 locus

  • Tissue-specific rescue using the GAL4-UAS system to express VPS29 in specific cell types

  • Cross-species rescue using human VPS29 cDNA to test functional conservation

Each of these approaches has specific advantages, and combining multiple genetic strategies provides the most comprehensive understanding of VPS29 function.

What biochemical and imaging techniques are most informative for studying VPS29 and retromer function?

A combination of biochemical and imaging techniques has been instrumental in elucidating VPS29 and retromer function. For biochemical analyses, co-immunoprecipitation experiments have been valuable for assessing protein-protein interactions, such as the association between VPS29, VPS35, and VPS26 . Western blotting with specific antibodies provides information about protein expression levels and can reveal changes in retromer components or interacting proteins like Rab7 in VPS29 mutants .

For imaging studies, immunofluorescence microscopy allows visualization of protein localization within cells and tissues. This approach revealed the mislocalization of retromer components from neuropil to neuronal cell bodies in VPS29 mutants . Confocal microscopy with markers for different cellular compartments (e.g., Arl8 and Spinster for late endosomes/lysosomes) helps determine the subcellular distribution of retromer in normal and pathological states .

Electron microscopy provides ultrastructural information that is particularly valuable for assessing endolysosomal morphology and function. Transmission electron microscopy (TEM) of tissue sections from VPS29 mutant animals revealed detailed changes in lysosomal structures, multivesicular bodies, and autophagic vacuoles that wouldn't be visible with light microscopy .

Additionally, functional assays such as electroretinogram (ERG) recordings for assessing synaptic transmission and climbing assays for evaluating locomotor function provide important physiological readouts of retromer dysfunction .

How can proteomics approaches advance our understanding of VPS29's role in cargo selection?

Proteomics approaches offer significant potential for advancing our understanding of VPS29's role in retromer function and cargo selection, though the search results don't specifically discuss proteomic studies of VPS29. Based on the biology of retromer and VPS29, several proteomics strategies would be valuable:

Proximity-based labeling techniques such as BioID or APEX could identify proteins that transiently interact with VPS29 in living cells. By fusing VPS29 to a promiscuous biotin ligase, proteins in close proximity would become biotinylated and could subsequently be purified and identified by mass spectrometry. This approach could reveal both stable and transient interactions that might be missed by traditional co-immunoprecipitation.

Comparative proteomics of endosomal fractions from wild-type versus VPS29-deficient cells could identify cargo proteins that depend on VPS29 for proper trafficking. Stable isotope labeling with amino acids in cell culture (SILAC) combined with subcellular fractionation would allow quantitative comparison of protein levels in different cellular compartments, potentially revealing cargo that accumulates in endosomes when VPS29 is absent.

Additionally, phosphoproteomics could be useful given that VPS29 has been proposed to have phosphatase-like domains. Comparing the phosphorylation status of proteins in normal versus VPS29-deficient conditions might reveal substrates affected by VPS29 activity, either directly or indirectly through retromer-associated proteins.

Product Science Overview

Structure and Function

VPS29 is part of a larger multimeric complex known as the retromer complex. This complex is essential for the proper sorting and trafficking of proteins within the cell. The retromer complex typically consists of VPS26, VPS29, and VPS35, along with sorting nexins (SNX1 and SNX2) which are involved in the retrograde transport of proteins from endosomes to the trans-Golgi network .

The crystal structure of human VPS29 reveals that it participates in the formation of the retromer complex by binding to other components such as VPS26 and VPS35. This interaction is crucial for the stability and function of the retromer complex .

Biological Role

VPS29 is involved in several key biological processes, including:

  • Protein Transport: It facilitates the transport of proteins from endosomes back to the trans-Golgi network, ensuring that proteins are correctly sorted and delivered to their intended destinations .
  • Regulation of Autophagy: VPS29 plays a role in the regulation of autophagy, a process that helps maintain cellular homeostasis by degrading and recycling cellular components .
  • Wnt Signaling Pathway: It is also involved in the Wnt signaling pathway, which is important for cell development and differentiation .
Clinical Significance

Mutations or dysfunctions in the VPS29 gene can lead to disruptions in protein trafficking, which may result in various cellular and physiological abnormalities. Understanding the structure and function of VPS29 is therefore crucial for developing potential therapeutic strategies for diseases related to protein sorting and trafficking.

Research and Applications

Recombinant human VPS29 is widely used in research to study its role in the retromer complex and its interactions with other proteins. This research is essential for elucidating the molecular mechanisms underlying protein sorting and trafficking within cells.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.